Education

1995   B. Sc in Medical Sciences, Hebrew University, Jerusalem, Israel

1998   MD, Hebrew University Medical School, Jerusalem, Israel

Postdoctoral training

1999-2001   Rotating Internship, Hadassah University hospitals

2001-2005  Internal Medicine residency, Internal medicine ward A, Ein Kerem, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

2005-2006  Hematology department, Hadassah- Hebrew University Medical  Center, Jerusalem, Israel

2006-           Residency in infectious diseases- Hadassah- Hebrew University Medical Center, Jerusalem, Israel

Academic appointments

2003            Instructor, Hebrew University medical school

Grants

Joint research grant of the Hebrew university and Hadassah medical center, 2004.

Awards

1993           Dean Scholarship-Excellency award for academic achievements during first year in medical school.

1995           Excellency award for academic achievements during pre-clinical  medical school years.

1997           Excellency award for academic achievements during clinical medical school years in medical school

1998           Class representative for medical students exchange program at Mount Sinai University Hospital, New-York, NY, USA

List of publications

1.  Plasma oxidizability and plasma carbonyls, markers of oxidative stress, in transplant patients.  Elinav H, Kohen R, Granot E. Trnasplant Proc 2001 sep 33(6):2918-9.

2.  Markers of oxidative stress in cyclosporine-treated and tracrolimus-treated children  after liver transplantation. Granot E, Elinav H, Kohen R. Liver  Transpl. 2002 May:8(5):469-475.

3.  Retroperitoneal fibrosis-clinical response to steroid treatment. Elinav H, .Hersko A ,Libobithch G, Naparstek Y Harefuah 2003 Mar;142 (3):166-169.

4.  Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"? Margalit M, Elinav H, Goldin E, Ilan Y.Harefuah. 2003 Jun;142(6):421-5, 486.

5.  Deep infection by Trichophyton rubrum in an immunocompromised patient. Nir-Paz R, Elinav H, Pierard GE, Walker D, Maly A, Shapiro M, Barton RC, Polacheck I.J Clin Microbiol. 2003 Nov;41(11):5298-301.

6.  Idiopathic liver involvement in Turner syndrome.  Elinav H, Israeli E, Shibolet O, Hershko A, Sela C, Migdal A, Ilan Y. Isr Med Assoc J. 2004 Jan;6(1):56-7. Review.

7.  The coexistence of Sweet`s syndrome and Still`s disease-is it merely a coincidence?  Elinav H, Maly A, Ilan Y, Rubinow A, Naparstek Y,  Amital H.  J Am Acad Dermatol. 2004 May;50(5 Suppl):S90-2.

8.  Differential role of platelet granular mediators in angiogenesis. Brill A, Elinav H, (Co- authors )Varon D. Cardiovasc Res. 2004 Aug 1;63(2):226-35. Erratum in: Cardiovasc Res. 2004 Nov 1;64(2):374.

9.  Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. Margalit M, Elinav H, Ilan Y, Shalit M. J Gastroenterol Hepatol. 2004 Dec;19(12):1338-42.

10.  Plantar ulcers and eyebrow-hair paucity.  Elinav H, Palladas L, Appelbaum YH, Gilaed L,Moses AE, Cohen-Poradosu R. Clin Infect Dis. 2006 Mar 1;42(5):684-5, 722-4.

11. In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment.  Elinav H, Wolf Z, Szalat A, Bdolah-Abram T, Glazer B, Raz I, Leibowitz G
Curr Med Res Opin. 2007 Apr;23(4):757-65.

Abstracts and presentations in conferences

1.  Idiopathic liver involvement in Turner’s syndrome- a clinical study of 55 patients. Oral presentation at the Israel association for the study of the liver-February 2002.

2.  Chylous ascites-a clinical mystery-clinical presentation. Oral presentation at the Israel association for the   study of the liver-September 2002.

3.  The value of suPAR (Soluble urokinase-type plasminogen activator receptor) levels as a laboratory parameter of follow-up in HIV positive patients –poster presentation at the Israeli Infectious Disease conference-June 2007.